Related references
Note: Only part of the references are listed.TNF-/calreticulin dual signaling induced NLRP3 inflammasome activation associated with HuR nucleocytoplasmic shuttling in rheumatoid arthritis
Yixin Liu et al.
INFLAMMATION RESEARCH (2019)
Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease
Steffen Bank et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients
Catarina Addobbati et al.
INFLAMMATION RESEARCH (2018)
NLRP3: A promising therapeutic target for autoimmune diseases
Hui-Hui Shen et al.
AUTOIMMUNITY REVIEWS (2018)
Galangin protects human rheumatoid arthritis fibroblast-like synoviocytes via suppression of the NF-κB/NLRP3 pathway
Qiang Fu et al.
MOLECULAR MEDICINE REPORTS (2018)
Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population
Quan-Bo Zhang et al.
CLINICAL RHEUMATOLOGY (2018)
Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1 via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients
P. Ruscitti et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis
Christianna Choulaki et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion
Hyo-Yeon Kim et al.
FEBS Journal (2015)
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
Rebeccah J. Mathews et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The NOD-Like Receptor Signalling Pathway in Helicobacter pylori Infection and Related Gastric Cancer: A Case-Control Study and Gene Expression Analyses
Natalia Castano-Rodriguez et al.
PLOS ONE (2014)
Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments
Moritz Haneklaus et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Association study of CARD8 (p.C10X) and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French and Tunisian populations
M. Ben Hamad et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2012)
NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223
Franz Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2012)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil
A. Pontillo et al.
AUTOIMMUNITY (2010)
The Inflammasomes: Guardians of the Body
Fablo Martinon et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
Shankar S. Iyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Gene Polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation
Deepti Verma et al.
ARTHRITIS AND RHEUMATISM (2008)
The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response
Daniel A. Muruve et al.
NATURE (2008)
Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (The Swedish TIRA project)
A. Kastbom et al.
RHEUMATOLOGY (2008)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
J Fransen et al.
RHEUMATOLOGY (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)